# Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-efficacy-and-safety-of-aliskiren-an-oral-direct-renin-inhibitor-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karl Andersen,Myron H. Weinberger,Brent M. Egan,Christian M. Constance,Mohammed A. Ali,James Jin,Deborah Keefe |
| Citations | 156 |
| DOI | 10.1097/hjh.0b013e3282f3ad9a |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2063358281 |
| PMID | 18300872 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Myron H. Weinberger](https://scholariq.org/researchers/myron-h-weinberger/)

## Paper journal

- [Journal of Hypertension](https://scholariq.org/journals/journal-of-hypertension/)

## Paper primary topic

- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)

## Paper topics

- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.